ARTICLE | Clinical News
Idalopirdine: Ph III STARBRIGHT data
February 10, 2017 9:20 PM UTC
Lundbeck said data from the double-blind, placebo-controlled, international Phase III STARBRIGHT trial in about 734 patients with mild to moderate AD who were on stable treatment with an acetylcholine...
BCIQ Target Profiles